For healthcare professionals only

Letters Hodgkin’s lymphoma

Personalised approach to treating early Hodgkin’s lymphoma

BMJ 2015; 350 doi: (Published 02 June 2015) Cite this as: BMJ 2015;350:h2927
  1. Tim Illidge, professor of clinical oncology1
  1. 1Institute of Cancer Sciences, University of Manchester, RRR Dept 58, Christie NHS Foundation Trust, Withington M20 4BX, UK
  1. tim.illidge{at}

As a coauthor of the original paper, I read the research news article “PET after chemotherapy identifies Hodgkin’s lymphoma patients who can avoid radiotherapy” with interest.1 The title grossly over-simplifies the increasingly challenging personalised decision making needed in responding to a “negative” positron emission tomography scan after initial chemotherapy in early Hodgkin’s lymphoma. The decision about whether to omit radiotherapy …

View Full Text

Log in

Log in through your institution


* For online subscription